Joint Clinical Trials Office

You are here

Genetic Markers of Longitudinal Course of PTSD Symptoms Following Traumatic Events

Clinical Trial Details

Weill Cornell Medical College researchers seek participants who experienced a traumatic event for a one year post traumatic stress disorder (PTSD) study. Participants will be assessed for PTSD and related symptomatology and followed up for 1 year. Participants will also contribute saliva sample for genetic biomarkers analysis.

This study aims to test genetic predictors of PTSD following trauma and to understand the longitudinal course of PTSD in trauma survivors, including psychiatric symptoms, impairment, and reaction to reintegration to daily life. All assessments are free of cost and confidential.

Key Eligibility: 

Inclusion

  • Have experienced a traumatic event
  • Are between the ages of 18 and 80 
  • Achieve Mini Mental Status Exam (MMSE) score of greater than 19 

Exclusion

  • MMSE score less than or equal to 19
  • Severe mental illness (e.g., psychosis, active suicidal/homicidal intent and plan) 

 

Study contact by location

Upper East Side - Manhattan

Contact(s)

Mariel Emrich
212-746-0783
mae2050@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1505016186

Status

Open to Enrollment